Furosemide Therapy Management

Introduction to Furosemide Therapy

In heart failure management, furosemide is typically used as a maintenance therapy with no specific time limitation as long as the patient requires diuresis, with the goal of maintaining euvolemia at the lowest achievable dose, requiring dose adjustments over time 1
The European Society of Cardiology recommends that once heart failure symptoms are controlled, diuretics should be maintained at the lowest effective dose 2

For cirrhotic ascites, guidelines recommend continuing diuretics as long as needed to control ascites, with the European Association for the Study of the Liver (EASL) stating that the goal of long-term treatment is to maintain patients free of ascites with the minimum dose of diuretics 3, 4
For recurrent ascites, furosemide is typically used in combination with aldosterone antagonists for long-term management 5

Regular monitoring is essential for patients on long-term furosemide therapy, including frequent clinical and biochemical monitoring during the first month of treatment, and ongoing monitoring of serum creatinine, sodium, and potassium levels, body weight, blood pressure, and clinical assessment for signs of dehydration or fluid overload 3, 4
Furosemide should be discontinued or the dose adjusted if severe hyponatremia, severe hypokalemia, progressive renal failure, worsening hepatic encephalopathy, or incapacitating muscle cramps occur 3, 4

The initial response phase involves starting with an appropriate dose, typically 40 mg/day for most adults, with subsequent adjustment to the minimum effective dose once the target clinical response is achieved, and continuation at the lowest effective dose as long as clinically indicated, with regular reassessment of the ongoing need for diuretic therapy 1